The 20 Best Lymphadenectomy Doctors Near Me

Find the Experts and Specialists who perform Lymphadenectomy

OverviewFind a DoctorLatest AdvancesClinical Trials
Advanced in Lymphadenectomy

Dr. Ashley F. Haggerty

Oncology
HackenSack Meridian health
Riverview Medical Center
1 Riverview Plaza, Gynecologic Oncology, 
Red Bank, NJ 
Advanced in Lymphadenectomy
HackenSack Meridian health
Riverview Medical Center
1 Riverview Plaza, Gynecologic Oncology, 
Red Bank, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ashley Haggerty is an Oncologist in Red Bank, New Jersey. Dr. Haggerty is rated as an Advanced provider by MediFind in Lymphadenectomy. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Lymphadenectomy.

Her clinical research consists of co-authoring 75 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Lymphadenectomy.

Graduate Institution
Bowman Gray School Of Medicine Of Wake Forest University
Specialties
Oncology
Licenses
Obstetrics & Gynecology in PA
Board Certifications
American Board Of Obstetrics And Gynecology
Fellowships
Hospital of the University of Pennsylvania
Hospital Affiliations
Ocean Medical Center
Riverview Medical Center
Bayshore Medical Center
Jfk University Medical Center
Jersey Shore University Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Riverview Medical Center
1 Riverview Plaza, Gynecologic Oncology, Red Bank, NJ 7701.
Call: 732-530-2410
Other Locations
1610 Route 88, Suite 203, Brick, NJ 8724.
Call: 732-897-7944
1100 Route 72 West, Suite 203, Manahawkin, NJ 8050.
Call: 732-897-7944
Jersey Shore University Medical Center
19 Davis Avenue, Floor 7, Neptune, NJ 7753.
Call: 732-897-7944

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Drug, Procedure
Study Drugs: Carboplatin, Letrozole, Paclitaxel
Study Phase: Phase 3
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue
REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue
Enrollment Status: Completed
Publish Date: November 15, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drugs: VB-111, Paclitaxel
Study Phase: Phase 3
Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
Enrollment Status: Terminated
Publish Date: April 02, 2020
Intervention Type: Other
View 4 Less Clinical Trials

75 Total Publications

A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer.
A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer.
Journal: Gynecologic oncology
Published: May 12, 2025
View All 75 Publications
Similar Doctors
Elite in Lymphadenectomy
Dr. Dimitrios Nasioudis
Oncology
Elite in Lymphadenectomy
Dr. Dimitrios Nasioudis
Oncology

Jordan Center For Gynecologic Cancers

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (88.1 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dimitrios Nasioudis is an Oncologist in Philadelphia, Pennsylvania. Dr. Nasioudis is rated as an Elite provider by MediFind in Lymphadenectomy. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Lymphadenectomy. Dr. Nasioudis is currently accepting new patients.

Distinguished in Lymphadenectomy
Dr. Emily M. Ko
Oncology
Distinguished in Lymphadenectomy
Dr. Emily M. Ko
Oncology

Penn Gynecologic Oncology Washington Square

800 Walnut Street, 10th Floor, 
Philadelphia, PA 
 (86.7 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Emily Ko is an Oncologist in Philadelphia, Pennsylvania. Dr. Ko is rated as an Elite provider by MediFind in Lymphadenectomy. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Lymphadenectomy. Dr. Ko is currently accepting new patients.

Distinguished in Lymphadenectomy
Dr. Mark A. Morgan
Oncology
Distinguished in Lymphadenectomy
Dr. Mark A. Morgan
Oncology

Jordan Center For Gynecologic Cancers

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (88.1 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances

Mark Morgan is an Oncologist in Philadelphia, Pennsylvania. Dr. Morgan is rated as an Elite provider by MediFind in Lymphadenectomy. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Hysterectomy, and Lymphadenectomy.

VIEW MORE LYMPHADENECTOMY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Haggerty's expertise for a condition
ConditionClose
  • Elite
  • Endometrial Cancer
    Dr. Haggerty is
    Elite
    . Learn about Endometrial Cancer.
    See more Endometrial Cancer experts
  • Distinguished
  • Endometrial Stromal Sarcoma
    Dr. Haggerty is
    Distinguished
    . Learn about Endometrial Stromal Sarcoma.
    See more Endometrial Stromal Sarcoma experts
  • Hysterectomy
    Dr. Haggerty is
    Distinguished
    . Learn about Hysterectomy.
    See more Hysterectomy experts
  • Ovarian Cancer
    Dr. Haggerty is
    Distinguished
    . Learn about Ovarian Cancer.
    See more Ovarian Cancer experts
  • Ovarian Carcinosarcoma
    Dr. Haggerty is
    Distinguished
    . Learn about Ovarian Carcinosarcoma.
    See more Ovarian Carcinosarcoma experts
  • Sertoli-Leydig Cell Tumor
    Dr. Haggerty is
    Distinguished
    . Learn about Sertoli-Leydig Cell Tumor.
    See more Sertoli-Leydig Cell Tumor experts
  • Advanced
  • Cervical Cancer
    Dr. Haggerty is
    Advanced
    . Learn about Cervical Cancer.
    See more Cervical Cancer experts
  • Lymphadenectomy
    Dr. Haggerty is
    Advanced
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Malignant Mixed Mullerian Tumor
    Dr. Haggerty is
    Advanced
    . Learn about Malignant Mixed Mullerian Tumor.
    See more Malignant Mixed Mullerian Tumor experts
  • Neuroendocrine Carcinoma of the Cervix
    Dr. Haggerty is
    Advanced
    . Learn about Neuroendocrine Carcinoma of the Cervix.
    See more Neuroendocrine Carcinoma of the Cervix experts
  • Testicular Yolk Sac Tumor
    Dr. Haggerty is
    Advanced
    . Learn about Testicular Yolk Sac Tumor.
    See more Testicular Yolk Sac Tumor experts
  • Vaginal Cancer
    Dr. Haggerty is
    Advanced
    . Learn about Vaginal Cancer.
    See more Vaginal Cancer experts
View All 7 Advanced Conditions
  • Experienced
  • Adenomyosis
    Dr. Haggerty is
    Experienced
    . Learn about Adenomyosis.
    See more Adenomyosis experts
  • Adult Soft Tissue Sarcoma
    Dr. Haggerty is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Angiomyoma
    Dr. Haggerty is
    Experienced
    . Learn about Angiomyoma.
    See more Angiomyoma experts
  • BRCA Positive Breast Cancer
    Dr. Haggerty is
    Experienced
    . Learn about BRCA Positive Breast Cancer.
    See more BRCA Positive Breast Cancer experts
  • Cervical Dysplasia
    Dr. Haggerty is
    Experienced
    . Learn about Cervical Dysplasia.
    See more Cervical Dysplasia experts
  • Desmoplastic Small Round Cell Tumor
    Dr. Haggerty is
    Experienced
    . Learn about Desmoplastic Small Round Cell Tumor.
    See more Desmoplastic Small Round Cell Tumor experts
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.